Heavy Insider Trading Reported As Cell Therapeutics Stock Soars

 

Shares of Cell Therapeutics Inc. (NASDAQ:CTIC) rose dramatically on Tuesday following an announcement that the company had launched a new treatment for for adults with multiply relapsed or refractory aggressive non-hodgkin B-cell lymphoma.

Read More...

 

Medicis Insiders Sell Millions Ahead of Valeant Deal

 

Shares of Medicis Pharmaceutical Corp. (NYSE:MRX) surged on Tuesday after it was reported that the skincare company would be bought by Valeant Pharmaceuticals in a $2.6 billion deal, Bloomberg reports.

Read More...

 

Did Eli Lilly Executives Know About Trial Drug's Shortcomings?

 

Pharmaceutical company Eli Lilly & Co. (NYSE:LLY) announced on Friday that its potential Alzheimer's treatment drug failed to hit the main targets of two late-stage studies, however other aspects of the trial showed the drug may slow the progress of memory loss for mild cases of the disease.

Read More...

 

What Is Causing Exelixis Insiders To Sell Stock?

 

At the end of Wednesday, August 8, Exelixis, Inc. (NASDAQ:EXEL) announced an upsized 30 million share offered priced at 0.7 percent, which led shares to rise in the following trading session.

Read More...

 

Did Warner Chilcott Insider Sell Stock Before Releasing Information?

 

Warner Chilcott Plc. (NASDAQ:WCRX), which makes drugs specially designed for women's health and dermatology, announced on Wednesday, August 8, that it had ended its efforts to sell the company, which caused its shares to fall nearly 7 percent.

Read More...

 

Are Gilead Executives Trading On Insider Information?

 

As Gilead Sciences Inc. (NASDAQ:GILD) announced a new collaboration with its Indian partners, hundreds of thousands of dollars' worth of insider trades have been made by some of the company's leading officials.

Read More...

 

Did Amarin Executives Trade Millions On Privileged Information?

 

Before shares of Amarin Corporation Plc. (NASDAQ:AMRN) dropped sharply on Friday, July 27, company officials filed millions of dollars' worth of insider trades with the SEC, begging the question: Were those trades made on information withheld from the public?

Read More...

 

What Does Vivus Know About The Upcoming FDA Decision?

 

Shares of VIVUS, Inc. (NASDAQ:VVUS), a weight-loss pharmaceutical company, fell on Monday before the U.S. Food and Drug Administration gave its decision on the drug, but it seems company officials may have an idea of the outcome.

Read More...

 

Mako Shares Tank On Sales Expectations Of Surgical Robot

 

Shares of Mako Surgical Corp. (NASDAQ:MAKO) plummeted on Tuesday after the company announced it expected to sell fewer surgical robots than it initially expected this year, heightening fears that the company may have trouble finding a buyer for the machine, Reuters reports.

Read More...

 

Questcor Pharma Stock Jumps On Sales Report, Director Still Selling Stock

 

Shares of Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) jumped on Monday after the company announced strong sales of its H.P. Acthar Gel, which has several broad uses and treats a number of different conditions.

Read More...

 

WellPoint Shares Fall After Healthcare Ruling

 

By upholding President Obama's healthcare law, U.S. insurers will receive an estimated 30 million new customers once the law's individual mandate goes into effect in 2014, however these companies will also need to implement expensive changes.

Read More...

 

Aetna Stocks Slide After Obamacare Announcement

 

The Supreme Court's ruling to uphold Obama's healthcare reform law will have a huge impact on insurance companies all over the nation. Shares of Aetna, Inc. (NYSE:AET) slid following the ruling, which it appears some company officials were ready for.

Read More...

 

Lincare Could Be Bought For $3.4 Billion

 

Lincare Holdings Inc. (NASDAQ:LNCR), a U.S.-based oxygen provider, may be the subject of a $3.4 billion buyout, with Germany's Linde AG leading the bidding, Reuters reports.

Read More...

 

Federal Court Supports Teva Patent, Shares Rise

 

Shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) rose higher on Monday after a federal court said the company still holds the patent to Copaxone, its largest brand name product used to treat multiple sclerosis.

Read More...

 

Celgene Withdraws Cancer Drug Application In EU

 

Celgene is opting out of applying for permission to expand the use of its blood cancer drug Revlimid following a series of questions EU drug officials asked about the medicine's links to other forms of cancer, The Wall Street Journal reports.

Read More...

 

Onyx Shares Soar On FDA Backing Of New Drug, Officials Still Selling Stock

 

Shares of Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) jumped 42 percent on Thursday after the U.S. Food and Drug Administration approved a new drug.

Read More...

 

J&J Takeover To Help Company In Orthopedic Surgery Market

 

Johnson & Johnson (NYSE:JNJ) recently completed a $19.7 billion takeover of Synthes, which the company says will help propel it toward the top of the blooming orthopedic surgery market, Bloomberg reports.

Read More...

 

Investors Respond Little To Merck Sleep Aid Advancements

 

Shares of Merck & Co. Inc. (NYSE:MRK) slid slightly on Wednesday despite an announcement that the company's new sleep aid could soon rival Ambien.

Read More...

 

BMY Gets Better Rating, But Company Insiders Are Still Selling Off

 

Bristol Myers Squibb Co. (NYSE:BMY) was recently upgraded by Standard and Poor's Ratings Services from A-1 to A-1+, but despite the favorable news, company officials, including director James Cornelius, have been selling off millions of shares in insider trades.

Read More...

 

Vertex Executives Profit Weeks Before Drug Fails

 

Vertex Pharmaceuticals (NASDAQ:VRTX) announced on Tuesday, May 29, that it had overstated the efficacy of its cystic fibrosis drug earlier in the month when it reported its clinical trials had better-than-expected results.

Read More...

 

Equities Review: Amylin Pharmaceuticals, Avago Technologies, Compuware and Research In Motion

 

Equities Review: Amylin Pharmaceuticals, Avago Technologies, Compuware and Research In Motion

Read More...

 

Hot Stocks: Coca-Cola, DaVita, Hertz Global Holdings and Nuance Communications

 

Hot Stocks: Coca-Cola, DaVita, Hertz Global Holdings and Nuance Communications

Read More...

 

Hot Stocks: Cheniere Energy, Hologic, Exelon, General Motors and Hartford Financial Services

 

Hot Stocks: Cheniere Energy, Hologic, Exelon, General Motors and Hartford Financial Services

Read More...

 

Express Scripts Stock Jumps On Strong Quarterly Report

 

Shares of Express Scripts Holding Co. (NSADAQ:ESRX) performed better than the market as a whole on Friday, following the pharmacy benefits manager's detailed analysis of the growth that was seen in the first quarter.

Read More...

 

Hot Stocks: Lam Research, Rio Tinto, Alere, Prudential Financial and ArcelorMittal

 

Hot Stocks: Lam Research, Rio Tinto, Alere, Prudential Financial and ArcelorMittal

Read More...

 

FDA Panel Finds New Pfizer Drug Safe, Effective

 

Federal health regulators announced on Wednesday that a new drug from Pfizer Inc. (NYSE:PFE) appears to be a safe and effective way for patients living with rheumatoid arthritis (RA) to treat their symptoms, The Wall Street Journal reports.

Read More...

 

Hot Stocks: Allscripts Healthcare Solutions, Fossil, Microchip Technology, Comcast and Ariad Pharmaceuticals

 

Hot Stocks: Allscripts Healthcare Solutions, Fossil, Microchip Technology, Comcast and Ariad Pharmaceuticals

Read More...

 

Arena Pharma's Diet Pill Under Question By FDA

 

The U.S. Food and Drug Administration (FDA) has returned its watchful eye to an experimental diet pill from Arena Pharmaceuticals (NASDAQ:ARNA), which the agency has previously rejected due to tumors and heart problems that have been linked with the drug, The Associated Press reports.

Read More...

 

Equities Review: Lululemon, First Solar, Intersil, Crocs and Ariad Pharmaceuticals

 

Equities Review: Lululemon, First Solar, Intersil, Crocs and Ariad Pharmaceuticals

Read More...

 

Vertex Shares Spike On Results Of New Study

 

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) stock jumped nearly 50 percent on Monday after the company announced the results of an ongoing study of a cystic fibrosis drug were better than the pharmaceutical developer had anticipated.

Read More...

 

Equities Review: Dendreon, Accenture, Thompson Creek Metals, Macy's and DISH Network

 

Equities Review: Dendreon, Accenture, Thompson Creek Metals, Macy's and DISH Network

Read More...

 

Stocks To Watch: CSX, JDS Uniphase, Hess, InvenSense and Dendreon

 

Stocks To Watch: CSX, JDS Uniphase, Hess, InvenSense and Dendreon

Read More...

 

Valeant Pharmaceuticals to Acquire Acne Medicine

 

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has reportedly agreed to a deal to acquire over-the-counter skin medicine AcneFree for $64 million in addition to performance payments.

Read More...

 

Stocks To Watch: Virgin Media, Level 3 Communications, CenterPoint Energy, Sprint Nextel and Aetna

 

Stocks To Watch: Virgin Media, Level 3 Communications, CenterPoint Energy, Sprint Nextel and Aetna

Read More...

 

Herbalife Shares Drop On Hedge Fund Manager's Questions

 

Shares of Herbalife Ltd. (NYSE:HLF) fell after hedge fund manager David Einhorn asked the supplement maker about its weight loss products, and why it has ceased to provide information on its distributors.

Read More...

 

Lower Humana Profits Weigh Heavy on UnitedHealth Shares

 

Shares of UnitedHealth Group Inc. (NYSE:UNH) took a spill on Monday on news that rival insurance company Humana Inc. reported quarterly profits below analysts' marks, and announced higher costs in its Medicare Advantage division, CBS News reports.

Read More...

 

Allscripts Shares Plummet On Company-Wide Restructuring

 

Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) which provides electronic records in the healthcare industry, saw its shares drop the most in three years after a drastic shakeup among company board members.

Read More...

 

Stocks To Watch: Logitech International, Varian Medical Systems, US Airways Group, Newmont Mining and Equinix

 

Stocks To Watch: Logitech International, Varian Medical Systems, US Airways Group, Newmont Mining and Equinix

Read More...

 

Hot Stocks: Warner Chilcott, VIVUS, Southwestern Energy, Du Pont and Goodyear Tire & Rubber

 

Hot Stocks: Warner Chilcott, VIVUS, Southwestern Energy, Du Pont and Goodyear Tire & Rubber

Read More...

 

Hot Stocks: ARM Holdings plc, Gilead Sciences, Alcoa, Medtronic and Parker-Hannifin

 

Hot Stocks: ARM Holdings plc, Gilead Sciences, Alcoa, Medtronic and Parker-Hannifin

Read More...

 

Equities Review: American International Group, KeyCorp, 3M, Align Technology and Altera

 

Equities Review: American International Group, KeyCorp, 3M, Align Technology and Altera

Read More...

 

Hot Stocks: Lennar, Hanesbrands, MGM Resorts International, Xerox and Mylan

 

Hot Stocks: Lennar, Hanesbrands, MGM Resorts International, Xerox and Mylan

Read More...

 

Human Genome Sciences turns down $2.59 billion offer from GlaxoSmithKline

 

Human Genome Sciences Inc. (NASDAQ:HGSI) was presented with an unsolicited $2.59 billion takeover offer from GlaxoSmithKline PLC on Thursday, but turned down the deal, saying it undervalues the company.

Read More...

 

SXC Health to Purchase Catalyst for More than $4 Billion

 

SXC Health Solutions Corp. (NASDAQ:SXCI) announced it plans to take over competing pharmacy benefits manager (PBM) Catalyst Health Solutions Inc. (CHSI) in a $4 billion deal only one month after major competitor Express Scripts sealed a $29.1 billion takeover, The Associated Press reports.

Read More...

 

Hot Stocks: Tibco Software, Merck, Calpine, Regions Financial and SandRidge Mississippian Trust

 

Hot Stocks: Tibco Software, Merck, Calpine, Regions Financial and SandRidge Mississippian Trust

Read More...

 

Walgreen Co. added to UBS' 'most preferred' list

 

Walgreen Co. (NYSE:WAG) shares jumped 5 percent on Tuesday on the announcement that UBS included the nationwide drugstore chain on its "most preferred" list, as well as a potential resolution to the company's tiff with Express Scripts, Reuters reports.

Read More...

 

Hot Stocks: Yamana Gold, Comerica, PepsiCo, Arena Pharmaceuticals and United Continental Holdings

 

Hot Stocks: Yamana Gold, Comerica, PepsiCo, Arena Pharmaceuticals and United Continental Holdings

Read More...

 

Equity Review: International Business Machines, American Eagle Outfitters, Forest Laboratories, Huntington Bancshares and Netflix

 

Equity Review: International Business Machines, American Eagle Outfitters, Forest Laboratories, Huntington Bancshares and Netflix

Read More...

 

Hot Stocks: Suncor Energy, SanDisk, Clearwire, Marvell and Boston Scientific

 

Hot Stocks: Suncor Energy, SanDisk, Clearwire, Marvell and Boston Scientific

Read More...

 

Equities Review: UnitedHealth Group, Cognizant Technology Solutions, Altria Group, E*TRADE and Ivanhoe Mines

 

Equities Review: UnitedHealth Group, Cognizant Technology Solutions, Altria Group, E*TRADE and Ivanhoe Mines

Read More...

 

Illumina Shares Drop After Rejection of Bid From Roche

 

Shares of Illumina Inc. (NASDAQ:ILMN) fell on Thursday after it rejected unsolicited takeover bids from Roche Holding AG for the second time, Bloomberg reports.

Read More...

 

Hot Stocks: Netflix, Mylan, Broadcom, MIPS Technologies and Applied Materials

 

Hot Stocks: Netflix, Mylan, Broadcom, MIPS Technologies and Applied Materials

Read More...

 

Equities Review: McDonald's Corporation, Advanced Micro Devices, Electronic Arts, Bristol Myers Squibb, and Host Hotels and Resorts

 

Equities Review: McDonald's Corporation, Advanced Micro Devices, Electronic Arts, Bristol Myers Squibb, and Host Hotels and Resorts

Read More...

 

Hot Stocks: Annaly Capital Management, Caterpillar, Target, Eli Lilly, and Walgreen

 

Hot Stocks: Annaly Capital Management, Caterpillar, Target, Eli Lilly, and Walgreen

Read More...

 

Abbott hepatitis C drug shows promise where other drugs have failed

 

An experimental hepatitis C treatment developed by Abbott Laboratories (ABT) has cured nearly half of the patients who did not respond to other therapies currently being used to treat the disease, a new study shows.

Read More...

 

Keryx shares fall on news of treatment failure in late-stage trials

 

Shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) dropped by a significant margin in trading on Monday, April 2, 2012, after the drug company announced that its experimental treatment for colorectal cancer failed in late-stage clinical trials.

Read More...

 

Hot Stocks: Capital One Financial, NetApp, Nabors Industries, Abbott Laboratories, and DDR

 

Hot Stocks: Capital One Financial, NetApp, Nabors Industries, Abbott Laboratories, and DDR

Read More...

 

Equities Review: Procter & Gamble, Threshold Pharmaceuticals, Discover Financial Services, Genworth Financial and Banco Santander

 

Equities Review: Procter & Gamble, Threshold Pharmaceuticals, Discover Financial Services, Genworth Financial and Banco Santander

Read More...

 

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.